Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage
Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage
Background and Purpose— It has been suggested that the interleukin-1A (IL-1A) allele 2 is a risk factor for Alzheimer’s disease (AD). Because cerebral amyloid angiopathy–related hemorrhage (CAAH) often coexists with AD, we examined the IL-1A polymorphism in CAAH.
Methods— In a case-control study, patients with pathologically verified CAAH, AD patients without intracerebral hemorrhage, and neuropathologically normal control subjects were studied. DNA was extracted from brain tissue, and IL-1A was genotyped. Logistic regression was used to examine the IL-1A polymorphism in CAAH patients with and without AD compared with AD and non-AD control subjects.
Results— There were 42 patients with CAAH, 232 AD patients, and 167 non-AD control subjects. In age-adjusted analyses, there was no association between possession of IL-1A allele 2 and risk of CAAH compared with AD control subjects (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.45 to 1.97; P=0.87) or non-AD control subjects (OR, 0.94; 95% CI, 0.47 to 1.87; P=0.86). Stratifying for the presence of apolipoprotein E 2 or 4 demonstrated the known increased risk of CAAH from these lipoprotein E alleles. Subgroup analyses demonstrated a nonsignificant excess of the IL-1A 2,2 genotype in patients with CAAH and AD compared with those CAAH patients who did not have histological evidence indicating AD (OR, 2.17; 95% CI, 0.15 to 122.3; P=0.64). Comparisons between CAAH patients with AD and AD control subjects and between CAAH patients without AD and non-AD control subjects did not demonstrate an association between CAAH and possession of either the IL-1A allele 2 or the 2,2 genotype.
Conclusions— The IL-1A allele 2 or 2,2 genotype does not appear to be a major risk factor for CAAH.
cerebral amyloid angiopathy, interleukins, intracerebral hemorrhage
e193-e195
McCarron, M.O.
49985d16-f2e0-4d44-aad0-2591fcbeb4c3
Stewart, J.
856808fb-3362-46ea-b9ed-aa64db4fc983
McCarron, P.
6f069205-047a-4833-9eb9-8ed59b1110af
Love, S.
de3ec24d-be42-4ca4-967d-b05436b6adc9
Vinters, H.V.
9aad3b3b-9a06-4a64-a58d-039448a3f403
Ironside, J.W.
31ba7264-6b8b-4993-92fc-36c2cd8d4226
Mann, D.M.
c164b508-516a-442a-8589-6e1d0d62d482
Graham, D.I.
0b1c9c9e-94b2-44fa-b189-8e04501b3a67
Nicoll, J.A.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
2003
McCarron, M.O.
49985d16-f2e0-4d44-aad0-2591fcbeb4c3
Stewart, J.
856808fb-3362-46ea-b9ed-aa64db4fc983
McCarron, P.
6f069205-047a-4833-9eb9-8ed59b1110af
Love, S.
de3ec24d-be42-4ca4-967d-b05436b6adc9
Vinters, H.V.
9aad3b3b-9a06-4a64-a58d-039448a3f403
Ironside, J.W.
31ba7264-6b8b-4993-92fc-36c2cd8d4226
Mann, D.M.
c164b508-516a-442a-8589-6e1d0d62d482
Graham, D.I.
0b1c9c9e-94b2-44fa-b189-8e04501b3a67
Nicoll, J.A.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
McCarron, M.O., Stewart, J., McCarron, P., Love, S., Vinters, H.V., Ironside, J.W., Mann, D.M., Graham, D.I. and Nicoll, J.A.
(2003)
Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage.
Stroke, 34 (10), .
Abstract
Background and Purpose— It has been suggested that the interleukin-1A (IL-1A) allele 2 is a risk factor for Alzheimer’s disease (AD). Because cerebral amyloid angiopathy–related hemorrhage (CAAH) often coexists with AD, we examined the IL-1A polymorphism in CAAH.
Methods— In a case-control study, patients with pathologically verified CAAH, AD patients without intracerebral hemorrhage, and neuropathologically normal control subjects were studied. DNA was extracted from brain tissue, and IL-1A was genotyped. Logistic regression was used to examine the IL-1A polymorphism in CAAH patients with and without AD compared with AD and non-AD control subjects.
Results— There were 42 patients with CAAH, 232 AD patients, and 167 non-AD control subjects. In age-adjusted analyses, there was no association between possession of IL-1A allele 2 and risk of CAAH compared with AD control subjects (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.45 to 1.97; P=0.87) or non-AD control subjects (OR, 0.94; 95% CI, 0.47 to 1.87; P=0.86). Stratifying for the presence of apolipoprotein E 2 or 4 demonstrated the known increased risk of CAAH from these lipoprotein E alleles. Subgroup analyses demonstrated a nonsignificant excess of the IL-1A 2,2 genotype in patients with CAAH and AD compared with those CAAH patients who did not have histological evidence indicating AD (OR, 2.17; 95% CI, 0.15 to 122.3; P=0.64). Comparisons between CAAH patients with AD and AD control subjects and between CAAH patients without AD and non-AD control subjects did not demonstrate an association between CAAH and possession of either the IL-1A allele 2 or the 2,2 genotype.
Conclusions— The IL-1A allele 2 or 2,2 genotype does not appear to be a major risk factor for CAAH.
This record has no associated files available for download.
More information
Published date: 2003
Keywords:
cerebral amyloid angiopathy, interleukins, intracerebral hemorrhage
Identifiers
Local EPrints ID: 27653
URI: http://eprints.soton.ac.uk/id/eprint/27653
ISSN: 0039-2499
PURE UUID: 63c510d1-2188-4923-bd79-09ae1526c15a
Catalogue record
Date deposited: 27 Apr 2006
Last modified: 08 Jan 2022 02:55
Export record
Contributors
Author:
M.O. McCarron
Author:
J. Stewart
Author:
P. McCarron
Author:
S. Love
Author:
H.V. Vinters
Author:
J.W. Ironside
Author:
D.M. Mann
Author:
D.I. Graham
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics